EchoMD Automated Ejection Fraction Software vs Autoplaque

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bay Labs (now Caption Health)
VS
by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

AI Verdict

While both are FDA-cleared AI tools for cardiac imaging, they address distinct clinical needs and utilize different imaging modalities. EchoMD focuses on automating left ventricular ejection fraction calculation from echocardiograms to assess heart function, whereas Autoplaque provides quantitative analysis of coronary plaques and stenoses from CT angiography for heart attack risk prediction. Therefore, they serve complementary rather than directly competing roles in cardiac evaluation.

Choose EchoMD Automated Ejection Fraction Software if…

Choose EchoMD Automated Ejection Fraction Software if your primary need is efficient and standardized assessment of left ventricular ejection fraction from echocardiograms. This tool is ideal for clinics and departments seeking to reduce variability and increase throughput in routine cardiac evaluations by automating clip selection and EF calculation.

View EchoMD Automated Ejection Fraction Software →

Choose Autoplaque if…

Choose Autoplaque if you require detailed quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This software is best suited for clinicians focused on advanced heart attack risk prediction and guiding treatment strategies based on a precise understanding of atherosclerotic burden.

View Autoplaque →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature EchoMD Automated Ejection Fraction Software Autoplaque
Pricing Contact for pricing Unknown
Deployment On-premise (via DICOM PACS integration) Workstation-based post-processing application, runs on Windows or Mac OS.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoMD Automated Ejection Fraction Software

EchoMD emphasizes full automation, performing EF calculations without user intervention and integrating seamlessly with DICOM PACS and EHR systems, streamlining existing workflows. Autoplaque, while fast, is workstation-based and requires trained users for reviewable and editable segmentations, suggesting a less fully automated workflow.

Clinical Value

Autoplaque

While EchoMD significantly improves the efficiency and reduces variability in a crucial cardiac measurement (EF), Autoplaque offers a more advanced clinical value by providing detailed quantitative analysis of coronary plaques and luminal stenoses from CT angiography. This enables enhanced heart attack risk prediction and treatment guidance, addressing a complex diagnostic challenge with potentially greater impact on preventative care.

Pricing & Value

Tie

Neither EchoMD nor Autoplaque disclose their enterprise pricing publicly. Both require direct contact for pricing information, making it impossible to assess their relative value propositions based on cost.

Enterprise Readiness

EchoMD Automated Ejection Fraction Software

EchoMD explicitly states HIPAA compliance, FDA clearance, and offers on-premise deployment with seamless DICOM PACS and EHR integration, along with SOC2 certification, indicating strong enterprise readiness. Autoplaque is FDA cleared but does not specify HIPAA compliance in the provided facts or search results, and its workstation-based deployment may be less scalable for large enterprise environments.

Innovation

Autoplaque

EchoMD demonstrates innovation by automating and standardizing the often variable process of EF calculation using deep learning. However, Autoplaque's AI-powered quantitative analysis of complex coronary plaque characteristics and stenosis from CT angiography, for heart attack risk prediction, represents a higher degree of innovation in tackling a more intricate and less standardized diagnostic challenge.

Support & Docs

Tie

Both tools provide general contact information for inquiries and support. However, neither offers specific details regarding dedicated support portals, service level agreements, or comprehensive public documentation beyond a mention of a user manual for Autoplaque, making a comparative judgment difficult.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature EchoMD Automated Ejection Fraction Software Autoplaque
Name EchoMD Automated Ejection Fraction Software Autoplaque
Company Bay Labs (now Caption Health) Cedars-Sinai Medical Center: AIM
Tagline AI-powered automated ejection fraction calculation for echocardiograms. AI-Powered Quantitative Analysis for Coronary Plaque and Stenosis
Primary Function Automated Left Ventricular Ejection Fraction (EF) calculation from echocardiograms Quantitative analysis of coronary plaques and luminal stenoses from CT angiography images
Input Modality Echocardiograms CT Angiography images
Specialties Cardiology, Critical Care, Emergency Medicine, Radiology Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring EchoMD Automated Ejection Fraction Software and Autoplaque.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

EchoMD Automated Ejection Fraction Software uses AI to automatically select optimal echocardiogram clips and calculate left ventricular ejection fraction (EF), improving efficiency and accuracy in cardiac evaluation. Autoplaque is an AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.
EchoMD Automated Ejection Fraction Software analyzes echocardiogram clips. Autoplaque performs quantitative analysis on CT angiography images.
EchoMD Automated Ejection Fraction Software is deployed on-premise via DICOM PACS integration, allowing seamless integration with existing systems. Autoplaque is a workstation-based software that runs on Windows or Mac computer platforms as a post-processing application.
EchoMD Automated Ejection Fraction Software provides automated Left Ventricular Ejection Fraction (EF) calculation and image quality rating. Autoplaque offers AI-powered quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, and measurement of luminal stenoses, vessel diameter, and area.
EchoMD Automated Ejection Fraction Software is designed for Cardiology, Critical Care, Emergency Medicine, and Radiology. Autoplaque is primarily for Cardiology and Radiology.
AI Tool Finder
AI-powered search. Results may not be comprehensive.